GTCR, Surmodics haven't shown deal helps consumers, US FTC, states say
MLex Summary: If medical device coaters GTCR and Surmodics are allowed to combine, device makers "and ultimately patients, will be hurt by the elimination of competition in the market for outsourced...To view the full article, register now.
Already a subscriber? Click here to view full article